335 related articles for article (PubMed ID: 3774040)
1. [Combination chemotherapy in leprosy].
Leiker DL
Ned Tijdschr Geneeskd; 1986 Oct; 130(43):1926-9. PubMed ID: 3774040
[No Abstract] [Full Text] [Related]
2. Multidrug therapy regimen for leprosy.
Firooz A
J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
[No Abstract] [Full Text] [Related]
3. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
Sansarricq H
Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
[No Abstract] [Full Text] [Related]
4. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
5. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
6. [Combination drug therapy in leprosy].
Terencio de las Aguas J
Acta Leprol; 1983; 1(3):143-50. PubMed ID: 6359802
[TBL] [Abstract][Full Text] [Related]
7. [Field experiences with therapy protocols in leprosy].
Pattyn SR
Verh K Acad Geneeskd Belg; 1983; 45(3):303-14. PubMed ID: 6364614
[No Abstract] [Full Text] [Related]
8. Chemotherapy of leprosy; "bubble" or "calendar" packs for the administration of rifampin, dapsone, clofazimine, or prothionamide/ethionamide.
Winsley BE; McDougall AC; Brown KE
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):592-4. PubMed ID: 6686974
[No Abstract] [Full Text] [Related]
9. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
Lockwood DN; Cunha Mda G
Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
[No Abstract] [Full Text] [Related]
10. Combined therapy of leprosy in Bhutan.
Samuel NM; Samuel S
Indian J Lepr; 1984; 56(3):647-52. PubMed ID: 6549335
[No Abstract] [Full Text] [Related]
11. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
Martinez Cruz D
Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
[No Abstract] [Full Text] [Related]
12. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
13. New approaches to chemotherapy for leprosy.
Waters MF
Drugs; 1983 Dec; 26(6):465-7. PubMed ID: 6653446
[No Abstract] [Full Text] [Related]
14. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance and multi-drug therapy in leprosy.
Chatterjee BR
Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881
[No Abstract] [Full Text] [Related]
17. Why multidrug therapy for multibacillary leprosy can be shortened to 12 months.
Ji B
Lepr Rev; 1998 Jun; 69(2):106-9. PubMed ID: 9715593
[No Abstract] [Full Text] [Related]
18. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
Paul S; Rose ET
Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
[No Abstract] [Full Text] [Related]
19. Shiny red-brown papules in a 21-year-old man. Histoid leprosy.
Aranda J; Hoang MP; Cohen JB
Arch Dermatol; 2004 Jun; 140(6):751-6. PubMed ID: 15210473
[No Abstract] [Full Text] [Related]
20. Evaluation of drug regimen in lepromatous leprosy--II.
Ramu G; Sreevatsa
Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
